Biosimilar of costly inflammatory bowel disease therapy found safe and effective

(Wiley) Treatment of Crohn's disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab (which targets tumour necrosis factor alpha), but at considerable cost.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news